Safety of Arthritis Drugs, Day 3, Part 3
At a joint meeting of the Arthritis and Drug Safety and Risk Management Advisory Committees, experts discussed the safety of arthritis drugs called “COX-2” inhibitors. Dr. Anne Trontell gave…
234 viewsAt a joint meeting of the Arthritis and Drug Safety and Risk Management Advisory Committees, experts discussed the safety of arthritis drugs called “COX-2” inhibitors. Dr. Anne Trontell gave…
234 viewsAt a joint meeting of the Arthritis and Drug Safety and Risk Management Advisory Committees, members discussed the safety of drugs called “COX-2” inhibitors, such as Vioxx and Celebrex. Dr. …
290 viewsThe Food and Drug Administration’s Arthritis and Drug Safety and Risk Management Advisory Committees continued discussions in their joint meeting on possible safety of risks of “COX-2” inhib…
496 viewsDr. Villalba and others spoke at a meeting to assess the safety records of arthritis drugs. They talked about testing and approval of the drug Vioxx and its subsequent use by American consum…
354 viewsPhysicians spoke at a meeting to assess the safety records of arthritis drugs. Representatives for the drugs Celebrex, Bextra, Parecoxib, and Naproxen spoke as did representatives for the Fo…
337 viewsA joint meeting of the Food and Drug Administration’s Arthritis and Drug Safety and Risk Management Advisory Committees held a forum on the safety of “COX-2” inhibitors. The function of the …
230 views